Acute myocardial infarction

All type of patients:  1 trials  - DIAMOND MI

dofetilide vs placebo

No demonstrated result

Atrial fibrillation

Maintaining sinus rhythm after cardioversion:  2 trials  - DIAMOND - SAFIRE-D

dofetilide vs placebo

No demonstrated result

suggested Atrial fibrillation recurrence by 32% (not demonstrated)

suggested Pro-arrhythmia by 471% (not demonstrated)

Post myocardial infarction

All type of patients:  1 trials  - DIAMOND MI

dofetilide vs placebo

No demonstrated result